MedTrace Logo

Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects

NCT01440426 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 187

Last updated 2018-07-13

No results posted yet for this study

Summary

This study deals with coverage of multiple denuded roots. The current standard treatment requires surgical correction and uses soft tissue taken from the roof of the mouth to enhance results. The hypothesis of this trial is that a synthetic collagen matrix (called Mucograft) can be used to replace soft tissue taken from the subject. If the collagen matrix will prove to be equally as effective as the patient own tissue, it will be possible to avoid a more extensive surgery and decrease pain and discomfort.

Conditions

  • Gingival Recession

Interventions

PROCEDURE

Autologous connective tissue graft with rotated papilla flap

Subepithelial connective tissue graft harvested from hard palate

DEVICE

Collagen matrix construct (Mucograft)

Mucograft Collagen Matrix combined with rotated papilla flap

Sponsors & Collaborators

  • The European Research Group on Periodontology (ERGOPerio)

    collaborator NETWORK

  • Maurizio Tonetti

    lead NETWORK

Principal Investigators

  • Maurizio Tonetti, DMD PhD · The European Research Group on Periodontology (ERGOPerio)

  • Pierpaolo COrtellini, MD · The European Research Group on Periodontology (ERGOPerio)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-06-30
Completion
2015-06-30

Countries

  • Belgium
  • Germany
  • Greece
  • Italy
  • Spain
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01440426 on ClinicalTrials.gov